FDA Inspection 1012031 — Ronald L. Drengler, M.D., Clinical Investigator

Ronald L. Drengler, M.D., Clinical Investigator — FEI 3012817798

The FDA completed an inspection of Ronald L. Drengler, M.D., Clinical Investigator on April 25, 2017 in San Antonio, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 25, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
751721 CFR 312.66Initial and continuing review